459 results on '"Niino, M."'
Search Results
2. DOCK10 mutant L1903Y complexed with Rac1
3. Crystal structure of the DHR-2 domain of DOCK10 in complex with Cdc42 (T17N mutant)
4. Crystal structure of the DHR-2 domain of DOCK10 in complex with Rac1
5. Crystal structure of human acetylcholinesterase in complex with tacrine
6. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan
7. Role of Vitamin D in Multiple Sclerosis Pathogenesis and Therapy
8. List of Contributors
9. Crystal structure of human acetylcholinesterase
10. Structure of human acetylcholinesterase in complex with tacrine
11. Crystal structure of human acetylcholinesterase in complex with donepezil
12. Development of a Thermal Shock Evaluation Device for Functionally Gradient Materials for Aerospace Applications
13. Thermal Fatigue Characteristics of Functionally Gradient Materials for Aerospace Applications
14. Cryo-EM structure of the human ELMO1-DOCK5-Rac1 complex
15. Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor
16. Design of a Concentration Solar Thermoelectric Generator
17. Crystal structure of the DOCK8 DHR-1 domain
18. Structure of the DOCK8 DHR-1 domain crystallized with di-C8-phosphatidylinositol-(4,5)-bisphosphate
19. Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report
20. Impact of screening with thyroid ultrasonography in myasthenia gravis patients
21. Solution structure of ELMO1 RBD
22. Approach for Compensation System of Asbestos-Related Lung Cancer
23. Effect of High Fat Diet on NKT Cell Function and NKT Cell-mediated Regulation of Th1 Responses
24. Nonhemorrhagic venous infarction of the spinal cord without spinal vascular malformation
25. Preparation and thermoelectric properties of p-type Si-Ge thermoelectric materials by mechanical alloying
26. Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis
27. p-n Joining of Melt-Grown and Sintered PbTe by Plasma Activated Sintering
28. FGM research programs in japan —from structural to functional uses
29. Database System for Project of the Functionally Graded Materials
30. DOCK7 mutant I1836Y complexed with Cdc42
31. Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
32. Prostaglandin E 1 protects cultured spinal neurons against the effects of nitric oxide toxicity
33. Baló's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient
34. Effect of plasma activated sintering (PAS) parameters on densification of copper powder
35. A local selection criterion for the composition of graded thermoelectric generators
36. Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
37. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan
38. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoic acid
39. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,N,4-trimethylpentanamide
40. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-N,4-dimethylpentanamide
41. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanamide
42. Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexyl)amino)-4-methylpentanoate
43. Useful scales for recognition of severe disease status in patients with multiple sclerosis in Japan
44. Safety of delayed-release dimetyl fumarate in Japanese patients with relapsing multiple sclerosis: Subgroup analysis of the apex Part 1 study
45. Assured diagnostic critera of myasthenia gravis by the task force for evidence-based diagnostic and therapeutic algorithms for the national policy of intractable diseases of Japan
46. Clinical and genetic features of Japanese patients with multiple sclerosis and neuromyelitis optica spectrum disorder based on Japan multiple sclerosis biobank
47. Evaluation of NEDA and clinical characteristics in multiple sclerosis patients with high serum sema4a levels
48. B cell-activating factor of the TNF family expands circulating transitional B cells in multiple sclerosis patients treated with fingolimod
49. Clinical features of ocular myasthenia gravis in japan
50. Crystal structure of the membrane-distal domain of mouse lysosome-associated membrane protein 2 (LAMP-2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.